{"id":"W3130126061","doi":"10.1056/nejmoa2100433","title":"Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19","year":2021,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":2032,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Children's Hospital of Pittsburgh; NIHR Imperial Biomedical Research Centre; Horizon 2020; Health Research Council of New Zealand; National Health and Medical Research Council; Canadian Institutes of Health Research; Université de Versailles Saint-Quentin-en-Yvelines; Minderoo Foundation; King Abdullah International Medical Research Center; Assistance publique-Hôpitaux de Paris; Universiteit Antwerpen; Universitätsklinikum Jena; Radboud Universitair Medisch Centrum; Queen's University; Fiona Stanley Hospital; Institut National de la Santé et de la Recherche Médicale; Université Pierre et Marie Curie; Ministère des Affaires Sociales et de la Santé; Seventh Framework Programme; Queen's University Belfast; King Saud bin Abdulaziz University for Health Science; Eisai; University of Oxford; Medical Research Council; Department of Health and Social Care; Health Research Board; National Institute for Health and Care Research; CRCMining; Université de Sherbrooke; Wellcome Trust; University College Dublin; Water Environment and Reuse Foundation; FP7 Health; University of Toronto; Helsingin Yliopisto; University of Alberta; European Commission; University of Pittsburgh; Breast Cancer Research Foundation; Amgen; National Institute of General Medical Sciences; Université Laval","keywords":"Interquartile range; Medicine; Tocilizumab; Odds ratio; Intensive care unit; Confidence interval; Internal medicine; Rheumatoid arthritis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}